In short, there are several reasons why more people and providers are experimenting with microdosing, ranging from cost and access challenges to adverse side effects at standard doses, as well as off-label uses such as appetite suppression, management of acute and chronic inflammation, impulse control, and adjunctive support in type 1 diabetes
In those cases the unit math changes a 0.25 mg dose at 3 mg/ml is about 8 units, not 25
But initial results were disappointing
Preclinical combination studies confirm that simultaneous GLP-1R and GIPR activation outperforms either receptor alone for weight reduction and glycemic control
Another 278 ( n= 18 in Spanish) interviews were conducted from a random digit dial telephone sample of prepaid cell phone numbers obtained through MSG
While GLP-1s are effective for weight loss, they are not clinically appropriate for everyone